Characterization of the solubility of a poorly soluble hydroxylated metabolite in human urine and its implications for potential renal toxicity.

The solubility, in human urine, of the major hydroxylated metabolite (M1) of an experimental cognition enhancer was characterized through a series of in vitro experiments in an effort to estimate the probability of crystalluria occurring following oral administration of the parent compound. The aim of these experiments was to determine if a safety margin existed between clinically observed urine concentrations and the solubility of M1. The mean urine concentrations of M1 in young and elderly subjects following oral administration of the parent compound at the highest doses tested, were 4865 +/- 2368 ng/mL and 2764 +/- 791 ng/mL, respectively. In vitro solubility experiments with M1 were conducted in drug-free human urine (37 degrees C) from four male and four female healthy subjects under conditions of high and low urine osmolality. Mean concentrations (n = 16) of M1 in human urine to which solid M1 was added, were 3656 +/- 621 ng/mL, 4678 +/- 1169 ng/mL and 5378 +/- 2474 ng/mL after stirring for 24, 48 and 72 h, respectively, indicating that the ex vivo mean solubility of M1 in human urine is no greater then approximately 5 microg/mL. Addition of solid M1 to urine from human subjects dosed with the parent compound resulted in mean urine M1 concentrations 23.5% greater than those observed in vivo. The results from both experiments indicated a significant overlap between urine concentrations of M1 in vivo following the highest oral administration of the parent drug and M1 solubility measured in vitro, suggesting a high potential for in vivo saturation of urine with M1 with subsequent precipitation, crystalluria, and nephrotoxicity. Consequently, the results of these studies have placed restrictions on the dose that could be administered during clinical development of this compound.

Solvent effects on the thioamide rotational barrier: an experimental and theoretical study.

The solvent effect on the C-N rotational barriers of N,N-dimethylthioformamide (DMTF) and N,N-dimethylthioacetamide (DMTA) has been investigated using ab initio theory and NMR spectroscopy. Selective inversion recovery NMR experiments were used to measure rotational barriers in a series of solvents. These data are compared to ab initio results at the G2(MP2) theoretical level. The latter are corrected for large amplitude vibrational motions to give differences in free energy. The calculated gas phase barriers are in very good agreement with the experimental values. Solvation effects were calculated using reaction field theory. This approach has been found to give barriers that are in good agreement with experiment for many aprotic, nonaromatic solvents that do not engage in specific interactions with the solute molecules. The calculated solution-phase barriers for the thioamides using the above solvents are also in good agreement with the observed barriers. The solvent effect on the thioamide rotational barrier is larger than that for the amides because the thioamides have a larger ground-state dipole moment, and there is a larger change in dipole moment with increasing solvent polarity. The transition-state dipole moments for the amides and thioamides are relatively similar. The origin of the C-N rotational barrier and its relation to the concept of amide "resonance" is examined.